PCM
MRNA icon

Polymer Capital Management’s Moderna MRNA Stock Holding History

Polymer Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$710K Buy
+13,968
New +$652K 0.07% 293
2025
Q4 		– Sell
-13,311
Closed -$344K – 921
2025
Q3 		$344K Buy
+13,311
New +$371K 0.04% 570

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Polymer Capital Management's MRNA Position: Q1 2026 in Review

Polymer Capital Management opened a new position in Moderna (MRNA) in Q1 2026: 13,968 shares worth $710K. The stake represents 0.07% of the portfolio and ranks #293 among its holdings. This is a return to the name: Polymer Capital Management previously reported a position in MRNA as recently as Q3 2025.

Polymer Capital Management first reported a position in MRNA in Q3 2025 and has held it in 2 quarters since. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Polymer Capital Management held 13,968 shares of Moderna worth $710K as of Q1 2026.
  • Moderna was a new Polymer Capital Management position in Q1 2026.
  • Moderna made up 0.07% of Polymer Capital Management's portfolio in Q1 2026, its #293 holding.
  • Polymer Capital Management first reported a position in Moderna in Q3 2025 and has held it in 2 quarters since.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Polymer Capital Management's 13F filing for Q1 2026, filed 14 May 2026.